HC Wainwright & Co. Initiates Coverage On Metagenomi with Buy Rating, Announces Price Target of $10
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Metagenomi (NASDAQ:MGX) with a Buy rating and a price target of $10.

May 07, 2024 | 10:10 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Metagenomi receives a Buy rating and a $10 price target from HC Wainwright & Co., indicating a positive outlook.
The initiation of coverage by a reputable analyst firm like HC Wainwright & Co. with a Buy rating and a specific price target usually signals a positive market outlook for the company. This can lead to increased investor interest and potentially a rise in stock price in the short term, especially if the market consensus aligns with this positive assessment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100